Adjuvant Tx Stage III-IV
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Adjuvant Tx Stage III-IV

› Forums › General Melanoma Community › Adjuvant Tx Stage III-IV

  • Post
    • October 31, 2013 at 7:17 pm
    SBeattie
    Participant

    Just wondering if anyone has any idea re: if/when PD-1 and combo with ipi  is FDA approved, it will be indicated for Stage III and IV 'resected' patients? I elected to watch/wait (the latter category) instead of enroll in the ipi 3mg or interferon trial, fearful of getting interferon (I know, if one doesn't try, then one will NEVER know) and fear of messing up getting into ipi-PD-1 trial if…more likely when, I may need it…unsights?

    Thank you all…

Viewing 2 reply threads
  • Replies
      • October 31, 2013 at 7:22 pm
      Janner
      Participant

      Your best bet would be to look at the current Phase III clinical trials for the drug or combo.  If they are doing phase III clinical trials for adjuvant therapy, the drugs will probably be approved for such (that is if trials show benefit in an adjuvant setting).  But if all the trials are for people with active disease, it's more likely that the drug will have the same constraints when it is approved.  The trials are a pretty good indication of after market approval.

        • November 1, 2013 at 1:06 pm
        SBeattie
        Participant

        Thank you so much Janner!

        • November 1, 2013 at 1:06 pm
        SBeattie
        Participant

        Thank you so much Janner!

        • November 1, 2013 at 1:06 pm
        SBeattie
        Participant

        Thank you so much Janner!

      • October 31, 2013 at 7:22 pm
      Janner
      Participant

      Your best bet would be to look at the current Phase III clinical trials for the drug or combo.  If they are doing phase III clinical trials for adjuvant therapy, the drugs will probably be approved for such (that is if trials show benefit in an adjuvant setting).  But if all the trials are for people with active disease, it's more likely that the drug will have the same constraints when it is approved.  The trials are a pretty good indication of after market approval.

      • October 31, 2013 at 7:22 pm
      Janner
      Participant

      Your best bet would be to look at the current Phase III clinical trials for the drug or combo.  If they are doing phase III clinical trials for adjuvant therapy, the drugs will probably be approved for such (that is if trials show benefit in an adjuvant setting).  But if all the trials are for people with active disease, it's more likely that the drug will have the same constraints when it is approved.  The trials are a pretty good indication of after market approval.

Viewing 2 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.